Capital International Investors Decreases Stock Position in Arch Capital Group Ltd. $ACGL

Capital International Investors cut its stake in shares of Arch Capital Group Ltd. (NASDAQ:ACGL) by 77.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,891,641 shares of the insurance provider’s stock after selling 6,612,322 shares during the quarter. Capital International Investors owned 0.52% of Arch Capital Group worth $171,629,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of ACGL. TD Waterhouse Canada Inc. raised its holdings in Arch Capital Group by 31.4% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 469 shares of the insurance provider’s stock valued at $43,000 after buying an additional 112 shares during the last quarter. Crescent Grove Advisors LLC grew its holdings in Arch Capital Group by 3.1% in the 2nd quarter. Crescent Grove Advisors LLC now owns 3,702 shares of the insurance provider’s stock worth $337,000 after acquiring an additional 112 shares during the last quarter. J.W. Cole Advisors Inc. increased its position in shares of Arch Capital Group by 4.4% in the second quarter. J.W. Cole Advisors Inc. now owns 3,025 shares of the insurance provider’s stock valued at $275,000 after acquiring an additional 127 shares during the period. Compound Planning Inc. increased its position in shares of Arch Capital Group by 5.0% in the third quarter. Compound Planning Inc. now owns 2,644 shares of the insurance provider’s stock valued at $240,000 after acquiring an additional 127 shares during the period. Finally, Cary Street Partners Investment Advisory LLC raised its stake in shares of Arch Capital Group by 5.1% during the second quarter. Cary Street Partners Investment Advisory LLC now owns 2,828 shares of the insurance provider’s stock valued at $257,000 after acquiring an additional 136 shares during the last quarter. 89.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Morgan Stanley set a $125.00 target price on Arch Capital Group in a research note on Friday, January 16th. Roth Mkm set a $110.00 price target on Arch Capital Group and gave the company a “buy” rating in a research report on Tuesday, December 2nd. Wells Fargo & Company increased their price objective on Arch Capital Group from $106.00 to $109.00 and gave the stock an “overweight” rating in a report on Wednesday, February 11th. Barclays set a $104.00 target price on Arch Capital Group and gave the company an “equal weight” rating in a research note on Thursday, January 8th. Finally, JPMorgan Chase & Co. upped their target price on Arch Capital Group from $111.00 to $117.00 and gave the company a “neutral” rating in a report on Wednesday, January 7th. Nine research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $109.20.

Insider Activity at Arch Capital Group

In related news, insider John M. Pasquesi sold 8,800 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $94.17, for a total transaction of $828,696.00. Following the completion of the transaction, the insider owned 289,556 shares of the company’s stock, valued at $27,267,488.52. This trade represents a 2.95% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Maamoun Rajeh sold 47,430 shares of Arch Capital Group stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $96.12, for a total value of $4,558,971.60. Following the transaction, the insider owned 433,589 shares of the company’s stock, valued at $41,676,574.68. The trade was a 9.86% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 260,096 shares of company stock worth $24,530,685 in the last 90 days. 4.20% of the stock is currently owned by company insiders.

Arch Capital Group Stock Performance

Shares of Arch Capital Group stock opened at $94.81 on Thursday. Arch Capital Group Ltd. has a 12 month low of $82.44 and a 12 month high of $103.39. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.13. The business has a fifty day simple moving average of $96.25 and a two-hundred day simple moving average of $93.00. The firm has a market capitalization of $33.73 billion, a P/E ratio of 8.16, a P/E/G ratio of 3.87 and a beta of 0.40.

Arch Capital Group (NASDAQ:ACGL) last announced its quarterly earnings data on Monday, February 9th. The insurance provider reported $2.98 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $0.64. Arch Capital Group had a net margin of 22.07% and a return on equity of 16.73%. The business had revenue of $4.93 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company earned $2.26 earnings per share. On average, equities analysts forecast that Arch Capital Group Ltd. will post 8.42 earnings per share for the current fiscal year.

Arch Capital Group Company Profile

Arch Capital Group Ltd. (NASDAQ: ACGL) is a Bermuda-based insurance and reinsurance holding company that underwrites a broad range of property and casualty, mortgage, and specialty risk products. The company operates through a group of underwriting subsidiaries and platforms to provide insurance, reinsurance and related risk solutions tailored to commercial, institutional and individual clients.

Arch’s product mix includes treaty and facultative reinsurance, primary casualty and property insurance, mortgage insurance and other specialty lines.